Homozygous deletion of ACSL3 in Korean TNBC patients, discovered via targeted exome sequencing, found the deletion to be associated with the increased risk of relapse and promoted distant metastasis in breast cancer patients, following adjunct chemotherapy treatment [112]. Here, ACSL3 is linked to breast carcinoma.